Last Updated: Monday, November 04, 2013
Principal Investigator: Jeremy M. Veenstra-VanderWeele, M.D.
Other researchers: Kevin Sanders, MD
We are seeking adult males age 18– 45 with autism spectrum disorder for a study using an investigational drug called RO5285119 – it is an investigational vasopressin antagonist.
The purpose of the study is to try and find out if this medication is safe and helpful in treating social and communication deficits found in patients with an autism spectrum disorder.
Evaluations, study visits, and study drug are provided at no cost.
You will be asked to come for up to 16 visits to Vanderbilt University in Nashville, TN to take part in this research study. There may be an opportunity for a nurse to come to your home for some of these visits. A blood draw is required at most visits.
This study is sponsored by Roche Pharmaceuticals.
Males ages 18-45 with diagnosis of autism spectrum disorder. Must be verbal.
$50 per site visit
6 visits to Vanderbilt University, plus 10 in-home visits
615 936 3288
Children age 6– 17 with an autism spectrum disorder who are taking an atypical antipsychotic like Risperidone (risperidol), Zyprexa (Olanzapine) and have gained unwanted weight.Compensation: Yes
Children age 6-18 with autism spectrum disorders with and without GI problems.Compensation: Yes
Visit this investigator's people page to list all of their studies together.